MCM
LH icon

Melvin Capital Management’s Labcorp LH Stock Holding History

Melvin Capital Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-899,416
Closed -$204M – 24
2022
Q1 		$204M Sell
899,416
-1,400,648
-61% -$329M 2.07% 26
2021
Q4 		$621M Buy
2,300,064
+88,464
+4% +$21.9M 3.03% 6
2021
Q3 		$535M Sell
2,211,600
-58,200
-3% -$14.7M 2.72% 7
2021
Q2 		$538M Buy
2,269,800
+523,800
+30% +$119M 3.09% 4
2021
Q1 		$383M Buy
1,746,000
+739,140
+73% +$148M 2.19% 9
2020
Q4 		$176M Sell
1,006,860
-888,139
-47% -$153M 0.74% 43
2020
Q3 		$307M Buy
1,894,999
+730,999
+63% +$116M 1.53% 23
2020
Q2 		$166M Sell
1,164,000
-1,828,586
-61% -$253M 0.98% 29
2020
Q1 		$325M Buy
2,992,586
+1,274,949
+74% +$184M 2.59% 11
2019
Q4 		$250M Sell
1,717,637
-634,198
-27% -$91.6M 2.05% 19
2019
Q3 		$339M Buy
2,351,835
+1,449,735
+161% +$212M 2.75% 10
2019
Q2 		$134M Buy
+902,100
New +$126M 1.37% 23

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Melvin Capital Management's LH Position: Q2 2022 in Review

Melvin Capital Management sold out of Labcorp (LH) in Q2 2022, closing a stake of 899,416 shares — an estimated $204M sold.

Melvin Capital Management first reported a position in LH in Q2 2019 and held it in 12 quarters. The position peaked at $621M in Q4 2021. 967 funds tracked by Wall St. Rank hold LH as of Q2 2022.

  • Melvin Capital Management reported no remaining Labcorp position as of Q2 2022 after selling out during the quarter.
  • Melvin Capital Management sold 899,416 Labcorp shares in Q2 2022, an estimated $204M.
  • Melvin Capital Management first reported a position in Labcorp in Q2 2019 and held it in 12 quarters.
  • Melvin Capital Management's Labcorp position peaked at $621M in Q4 2021.
  • 967 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on Melvin Capital Management's 13F filing for Q2 2022.